Rebastinib (DCC-2036) is a conformational control Bcr-Abl inhibitor for Abl1(WT) and Abl1(T315I) with IC50 of 0.8 nM and 4 nM, also inhibits SRC, LYN, FGR, HCK, KDR, FLT3, and Tie-2, and low activity to seen towards c-Kit. Phase 1.
| Quantity | 100mg, 500mg, 1 g |
|---|
Be the first to review “Rebastinib (DCC-2036)”
Related products
Powder for Hairloss Treatment Research
Price range: $120.00 through $700.00
Powder for Hairloss Treatment Research
Price range: $300.00 through $500.00
Powder for Hairloss Treatment Research
Price range: $300.00 through $5,000.00
Sale!
Powder for Hairloss Treatment Research
Price range: $320.00 through $2,800.00
Powder for Hairloss Treatment Research
Price range: $128.00 through $388.00
RU58841
Price range: $79.00 through $265.00
Powder for Hairloss Treatment Research
Price range: $150.00 through $500.00
Sale!
Powder for Hairloss Treatment Research
Price range: $165.00 through $255.00
Reviews
There are no reviews yet.